Maturation of bovine dendritic cells by lipopeptides

Veterinary Immunology and Immunopathology

Volumn 95, Issue 1-2, 2003, Pages 21-31

  Hope, Jayne C ^a   Whelan, Adam O ^b   Hewinson, R G ^b   Vordermeier, Martin ^b   Howard, Chris J ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

Dendritic cells; Lipopeptides; Macrophages; Mycobacterium bovis

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 12; LIPOPEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; BACTERIAL INFECTION; CATTLE; CELL MATURATION; CELL STIMULATION; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; EXPOSURE; IMMUNE RESPONSE; IMMUNOSTIMULATION; INTERMETHOD COMPARISON; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROORGANISM; NONHUMAN;

BACTERIA (MICROORGANISMS); BOVINAE; MYCOBACTERIUM; MYCOBACTERIUM BOVIS;

EID: 0041335377     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(03)00104-1     Document Type: Article

References (26)

1. Bessler W.G., Heinevetter L., Wiesmuller K.H., Jung G., Baier W., Huber M., Lorenz A.R., Esche U.V., Mittenbuhler K., Hoffmann P. Bacterial cell wall components as immunomodulators. I. Lipopeptides as adjuvants for parenteral and oral immunization. Int. J. Immunopharmacol. 19:1997;547-550.
2. Bessler, W.G., Baier, W., van de Esche, U., Hoffmann, P., Heinevetter, L., Wiesmuller, K.H., Jung, G., 1997b. Bacterial lipopeptides constitute efficient novel immunogens and adjuvants in parenteral and oral immunization. Behring. Inst. Mitt., pp. 390-399.
3. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., Maitland M., Norgard M.V., Plevy S.E., Smale S.T., Brennan P.J., Bloom B.R., Godowski P.J., Modlin R.L. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 285:1999;732-736.
4. Demangel C., Bean A.G., Martin E., Feng C.G., Kamath A.T., Britton W.J. Protection against Mycobacterium tuberculosis infection using Mycobacterium bovis bacillus Calmette Guerin-infected dendritic cells. Eur. J. Immunol. 29:1999;1972-1979.
5. Deres K., Schild H., Wiesmuller K.H., Jung G., Rammensee H.G. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature. 342:1989;561-564.
6. Hauschildt S., Hoffmann P., Beuscher H.U., Dufhues G., Heinrich P., Wiesmuller K.H., Jung G., Bessler W.G. Activation of bone marrow derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression. Eur. J. Immunol. 20:1990;63-68.
7. Henderson R.A., Watkins S.C., Flynn J.L. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 159:1997;635-643.
8. Hertz C.J., Kiertcher S.M., Godowski P.J., Bouis D.A., Norgard M.V., Roth M.D., Modlin R.L. Microbial lipopeptides stimulate dendritic cell maturation via toll like receptor 2. J. Immunol. 166:2001;2444-2450.
9. Hewinson R.G., Michell S.L., Russell W.P., McAdam R.A., Jacobs W.R. Jr. Molecular characterization of MPT83: a seroreactive antigen of Mycobacterium tuberculosis with homology to MPT70. Scand. J. Immunol. 43:1996;490-499.
10. Hoffmann P., Heinle S., Schade U.F., Loppnow H., Ulmer A.J., Flad H.D., Jung G., Bessler W.G. Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immunobiology. 177:1988;158-170.
11. Hope J.C., Kwong L.S., Sopp P., Collins R.A., Howard C.J. Dendritic cells induce CD4 and CD8 T cell responses to Mycobacterium bovis and M. avium antigens in BCG vaccinated and non-vaccinated cattle. Scand. J. Immunol. 52:2000;285-291.
12. Hope J.C., Kwong L.S., Entrican G., Vordermeier H.M., Sopp P., Duggan S., Howard C.J. Development of an ELISA for bovine IL-12. J. Immunol. Meth. 266:2002;117-126.
13. Kim K.D., Lee H.G., Kim J.K., Park S.N., Choe I.S., Choe Y.K., Kim S.J., Lee E., Lim J.S. Enhanced antigen presenting activity and tumour necrosis factor a dependent activation of dendritic cells following treatment with Mycobacterium bovis bacillus Calmette Guerin. Immunology. 97:1999;626.
14. Kolb-Maurer A., Gentschev I., Fries H.W., Fiedler F., Brocker E.B., Kampgen E., Goebel W. Listeria monocytogenes infected human dendritic cells: uptake and host cell response. Infect. Immun. 68:2000;3680.
15. Krutzik S.R., Sieling P.A., Modlin R.L. The role of toll like receptors in host defence against microbial infection. Curr. Opin. Immunol. 13:2001;104-108.
16. Kwong L.S., Hope J.C., Thom M.L., Sopp P., Duggan S., Bembridge G.P., Howard C.J. Development of an ELISA for bovine IL-10. Vet. Immunol. Immunopathol. 85:2002;213-223.
17. + T cells from αβ TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFNγ production is IFNγ dependent. Int. Immunol. 5:1993;1119-1128.
18. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature. 388:1997;394.
19. Noss E.H., Harding C.V., Boom W.H. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell. Immunol. 201:2000;63.
20. Noss E.H., Pai R.K., Sellati T.J., Radolf J.D., Belisle J., Golenbock D.T., Boom W.H., Harding C.V. Toll-like receptor 2 dependent inhibition of macrophage class II MHC expression and antigen processing by 19 kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 167:2001;910-918.
21. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1994;1109-1118.
22. Thoma-Uszynski S., Kiertscher S.M., Ochoa M.T., Bouis D.A., Norgard M.V., Miyake K., Godowski P.J., Roth M.D., Modlin R.L. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J. Immunol. 165:2000;3804-3810.
23. Thoma-Uszynski S., Stenger S., Takeuchi O., Ochoa M.T., Engele M., Sieling P.A., Barnes P.F., Rollinghoff M., Bolcskei P.L., Wagner M., Akira S., Norgard M.V., Belisle J.T., Godowski P.J., Bloom B.R., Modlin R.L. Induction of direct anti-microbial activity through mammalian toll-like receptors. Science. 291:2001;1544-1547.
24. Werling D., Hope J.C., Chaplin P., Collins R.A., Taylor G., Howard C.J. Involvement of caveolae in the uptake of respiratory syncytial virus antigen by dendritic cells. J. Leukocyte Biol. 66:1999;50-58.
25. Whelan, A.O., Hope, J.C., Howard, C.J., Clifford, D., Hewinson, R.G., Vordermeier, H.M., 2003. Modulation of the bovine delayed type hypersensitivity responses to defined mycobacterial antigens by a synthetic bacterial lipopeptide. Infection and Immunity., in press.
26. Wiesmuller K.H., Jung G., Hess G. Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator. Vaccine. 7:1989;29-33.